-
1
-
-
0027265413
-
Incidence, predictive factors and prognosis of the hepatorenal syndrome in cirrhosis and ascites
-
Gines A, Escorsell, Gines P, et al. Incidence, predictive factors and prognosis of the hepatorenal syndrome in cirrhosis and ascites. Gastroenterology. 1993;105:229-236.
-
(1993)
Gastroenterology
, vol.105
, pp. 229-236
-
-
Gines, A.1
Escorsell2
Gines, P.3
-
2
-
-
0000670254
-
Electrolyte and circulatory changes in terminal liver failure
-
Hecker R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure. Lancet. 1956;2:1221-1225.
-
(1956)
Lancet
, vol.2
, pp. 1221-1225
-
-
Hecker, R.1
Sherlock, S.2
-
3
-
-
0014684103
-
Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease
-
Koppel MH, Coburn JN, Mims MM, et al. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease. N Engl J Med. 1969;280:1367-1371.
-
(1969)
N. Engl. J. Med.
, vol.280
, pp. 1367-1371
-
-
Koppel, M.H.1
Coburn, J.N.2
Mims, M.M.3
-
4
-
-
0015755728
-
Recovery from hepatorenal syndrome after orthotopic liver transplantation
-
Iwatsuki S, Popovtzer MM, Corman Jl, et al. Recovery from hepatorenal syndrome after orthotopic liver transplantation. N Engl J Med. 1973;289:1155-1159.
-
(1973)
N. Engl. J. Med.
, vol.289
, pp. 1155-1159
-
-
Iwatsuki, S.1
Popovtzer, M.M.2
Corman, J.L.3
-
5
-
-
0030052899
-
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
-
Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 1996;23:164-176.
-
(1996)
Hepatology
, vol.23
, pp. 164-176
-
-
Arroyo, V.1
Gines, P.2
Gerbes, A.L.3
-
6
-
-
0037220559
-
Ascites and hepatorenal syndrome in cirrhosis: Pathophysiological basis of therapy and current management
-
Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol. 2003;38:S69-S89.
-
(2003)
J. Hepatol.
, vol.38
-
-
Arroyo, V.1
Colmenero, J.2
-
7
-
-
0034087697
-
Complications of cirrhosis. Renal and circulatory dysfunction lights and shadows in an important clinical problem
-
Arroyo V, Jimenez W. Complications of cirrhosis. Renal and circulatory dysfunction lights and shadows in an important clinical problem. J Hepatol. 2000;32:157-170.
-
(2000)
J. Hepatol.
, vol.32
, pp. 157-170
-
-
Arroyo, V.1
Jimenez, W.2
-
8
-
-
0022442745
-
Influence of the degree of liver failure on systemic and splanchnic hemodynamics and on response to propranonol in patients with cirrhosis
-
Braillon A, Cales P, Valla D, et al. Influence of the degree of liver failure on systemic and splanchnic hemodynamics and on response to propranonol in patients with cirrhosis. Gut. 1986;27:1204-1209.
-
(1986)
Gut
, vol.27
, pp. 1204-1209
-
-
Braillon, A.1
Cales, P.2
Valla, D.3
-
9
-
-
0026627932
-
The hemodynamic status of preascitic cirrhosis: An evaluation under steady-state conditions and after postural change
-
Bernardi M, Di Marco C, Trevisani F, et al. The hemodynamic status of preascitic cirrhosis: an evaluation under steady-state conditions and after postural change. Hepatology. 1992;16:341-346.
-
(1992)
Hepatology
, vol.16
, pp. 341-346
-
-
Bernardi, M.1
Di Marco, C.2
Trevisani, F.3
-
10
-
-
0027160767
-
Renal sodium retention during upright posture in preascitic cirrhosis
-
Bernardi M, Di Marco C, Trevisani F, et al. Renal sodium retention during upright posture in preascitic cirrhosis. Gastroenterology. 1993;105:188-193.
-
(1993)
Gastroenterology
, vol.105
, pp. 188-193
-
-
Bernardi, M.1
Di Marco, C.2
Trevisani, F.3
-
11
-
-
0028961435
-
Systemic hemodynamic, forearm vascular, renal and humoral response to sustained cardiopulmonary baroreceptor deactivation in cirrhosis
-
Wong F, Logan AG, Blendis LM. Systemic hemodynamic, forearm vascular, renal and humoral response to sustained cardiopulmonary baroreceptor deactivation in cirrhosis. Hepatology. 1995;21:717-724.
-
(1995)
Hepatology
, vol.21
, pp. 717-724
-
-
Wong, F.1
Logan, A.G.2
Blendis, L.M.3
-
12
-
-
0026597618
-
Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension
-
LaVilla G, Salmeron JM, Arroyo V, et al. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension. Gastroenterology. 1992;102:2114-2119.
-
(1992)
Gastroenterology
, vol.102
, pp. 2114-2119
-
-
LaVilla, G.1
Salmeron, J.M.2
Arroyo, V.3
-
13
-
-
0027409331
-
Glomerular hyperfiltration in patients with well compensated alcoholic cirrhosis
-
Wong F, Massie D, Colman J, Dudley F. Glomerular hyperfiltration in patients with well compensated alcoholic cirrhosis. Gastroenterology. 1993;104:884-889.
-
(1993)
Gastroenterology
, vol.104
, pp. 884-889
-
-
Wong, F.1
Massie, D.2
Colman, J.3
Dudley, F.4
-
14
-
-
0023749667
-
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
-
Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;1151-1157
-
(1988)
Hepatology
, pp. 1151-1157
-
-
Schrier, R.W.1
Arroyo, V.2
Bernardi, M.3
Epstein, M.4
Henriksen, J.H.5
Rodes, J.6
-
15
-
-
0027938229
-
Hyperdynamic circulation of liver disease 40 years later: Pathophysiology and clinical consequences
-
Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology. 1994;20:1359-1363.
-
(1994)
Hepatology
, vol.20
, pp. 1359-1363
-
-
Groszmann, R.J.1
-
17
-
-
0026021317
-
Increased sympathetic outflow in cirrhosis and ascites: Direct evidence from intraneural recordings
-
Floras JS, Legault L, Morali GA, Hara K, Blendis LM. Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings. Ann Intern Med. 1991;114:373-380.
-
(1991)
Ann. Intern. Med.
, vol.114
, pp. 373-380
-
-
Floras, J.S.1
Legault, L.2
Morali, G.A.3
Hara, K.4
Blendis, L.M.5
-
18
-
-
0035183540
-
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis
-
Pozzi M, Grassi G, Redaelli E, et al. Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis. Hepatology. 2001;34:1113-1118.
-
(2001)
Hepatology
, vol.34
, pp. 1113-1118
-
-
Pozzi, M.1
Grassi, G.2
Redaelli, E.3
-
19
-
-
0031160109
-
The controversy of the pathophysiology of ascites in cirrhosis
-
Wong F, Girgrah N, Blendis LM. The controversy of the pathophysiology of ascites in cirrhosis. J Gastroenterol Hepatol. 1997;12:437-444.
-
(1997)
J. Gastroenterol. Hepatol.
, vol.12
, pp. 437-444
-
-
Wong, F.1
Girgrah, N.2
Blendis, L.M.3
-
20
-
-
0029087768
-
Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal plasma renin, aldosterone and norepinephrine levels
-
Salo J, Gines A, Anibarro L, et al. Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal plasma renin, aldosterone and norepinephrine levels. Hepatology. 1995;22:479-487.
-
(1995)
Hepatology
, vol.22
, pp. 479-487
-
-
Salo, J.1
Gines, A.2
Anibarro, L.3
-
21
-
-
0022466521
-
Renal function abnormalities prostaglandins and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis
-
Arroyo V, Gines P, Rimola A, et al. Renal function abnormalities prostaglandins and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis. Am J Med. 1986;81:104-122.
-
(1986)
Am. J. Med.
, vol.81
, pp. 104-122
-
-
Arroyo, V.1
Gines, P.2
Rimola, A.3
-
22
-
-
0027932725
-
Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites
-
Angeli P, Jimenez W, Arroyo V, et al. Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites. Hepatology. 1994;20:948-954.
-
(1994)
Hepatology
, vol.20
, pp. 948-954
-
-
Angeli, P.1
Jimenez, W.2
Arroyo, V.3
-
23
-
-
0029080711
-
Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis
-
Ros J, Claria J, Jimenez W, et al. Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis. Hepatology. 1995;22:915-920.
-
(1995)
Hepatology
, vol.22
, pp. 915-920
-
-
Ros, J.1
Claria, J.2
Jimenez, W.3
-
24
-
-
84991133441
-
The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis
-
Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology. 1994;20:1343-1350.
-
(1994)
Hepatology
, vol.20
, pp. 1343-1350
-
-
Bomzon, A.1
Blendis, L.M.2
-
25
-
-
0027967857
-
Vasopressin release and water metabolism in patients with cirrhosis
-
Salerno D, DelBo A, Maggi A, Marabini M, Maffi M, Borroni GM, Moser P. Vasopressin release and water metabolism in patients with cirrhosis. J Hepatology. 1994;21:822-830.
-
(1994)
J. Hepatology
, vol.21
, pp. 822-830
-
-
Salerno, D.1
DelBo, A.2
Maggi, A.3
Marabini, M.4
Maffi, M.5
Borroni, G.M.6
Moser, P.7
-
26
-
-
0021132354
-
Evidence of renal prostaglandins are involved in renal water metabolisim in cirrhosis
-
Perez-Ayoso RM, Arroyo V, Camps J, et al. Evidence of renal prostaglandins are involved in renal water metabolisim in cirrhosis. Kidney Int. 1984;26:72-80.
-
(1984)
Kidney Int.
, vol.26
, pp. 72-80
-
-
Perez-Ayoso, R.M.1
Arroyo, V.2
Camps, J.3
-
27
-
-
0033658150
-
Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients
-
Borroni G, Maggi A, Sangiovanni A, Cazzaniga M, Salerno F. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis. 2000;32:605-610.
-
(2000)
Dig. Liver Dis.
, vol.32
, pp. 605-610
-
-
Borroni, G.1
Maggi, A.2
Sangiovanni, A.3
Cazzaniga, M.4
Salerno, F.5
-
28
-
-
0025044679
-
Regulation of the renal circulation
-
Stein J. Regulation of the renal circulation. Kidney Int. 1990;38:571-576.
-
(1990)
Kidney Int.
, vol.38
, pp. 571-576
-
-
Stein, J.1
-
29
-
-
0030910810
-
Hepatorenal syndrome
-
Moore K. Hepatorenal syndrome. Clin Sci. 1997;92:433-443.
-
(1997)
Clin. Sci.
, vol.92
, pp. 433-443
-
-
Moore, K.1
-
30
-
-
0035184982
-
Hepatorenal syndrome. Clinical Challenge
-
Wong F, Blendis LM. Hepatorenal syndrome. Clinical Challenge. Hepatology. 2001;34:1242-1251.
-
(2001)
Hepatology
, vol.34
, pp. 1242-1251
-
-
Wong, F.1
Blendis, L.M.2
-
31
-
-
0027506821
-
Effect of dipyridamole on kidney function in cirrhosis
-
Llach J, Gines P, Arroyo V, et al. Effect of dipyridamole on kidney function in cirrhosis. Hepatology. 1993;17;59-64.
-
(1993)
Hepatology
, vol.17
, pp. 59-64
-
-
Llach, J.1
Gines, P.2
Arroyo, V.3
-
32
-
-
0006111530
-
Arachidonic acid metabolites and the kidney in cirrhosis
-
Arroyo V, ed. Malden, Mass: Blackwell Science
-
Moore KP. Arachidonic acid metabolites and the kidney in cirrhosis. In: Arroyo V, ed. Ascites and renal dysfunction in liver disease. Malden, Mass: Blackwell Science; 1999:249-272.
-
(1999)
Ascites and Renal Dysfunction in Liver Disease
, pp. 249-272
-
-
Moore, K.P.1
-
33
-
-
0034770911
-
The hepatorenal syndrome
-
Dagher L, Moore K. The hepatorenal syndrome. Gut. 2001;49:729-737.
-
(2001)
Gut
, vol.49
, pp. 729-737
-
-
Dagher, L.1
Moore, K.2
-
34
-
-
0030979858
-
Reduction in renal blood flow following acute increase in the portal pressure: Evidence for the existence of a hepatorenal reflex in man?
-
Jalan R, Forrest EH, Redhead DN, et al. Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man? Gut. 1997;50:664-670.
-
(1997)
Gut
, vol.50
, pp. 664-670
-
-
Jalan, R.1
Forrest, E.H.2
Redhead, D.N.3
-
35
-
-
0033931614
-
Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: A phase II study
-
Brensing KA, Textor J, Perz J, et al. Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut. 2000;47:288-295.
-
(2000)
Gut
, vol.47
, pp. 288-295
-
-
Brensing, K.A.1
Textor, J.2
Perz, J.3
-
36
-
-
0031949661
-
Hepatorenal syndrome: Definition, pathophysiology, clinical features and management
-
Bataller R, Sort P, Gines P, Arroyo V. Hepatorenal syndrome: definition, pathophysiology, clinical features and management. Kidney Int. 1998;53 (suppl 66): S47-S53.
-
(1998)
Kidney Int.
, vol.53
, Issue.SUPPL. 66
-
-
Bataller, R.1
Sort, P.2
Gines, P.3
Arroyo, V.4
-
37
-
-
0036098337
-
Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment
-
Arroyo V, Guevara M, Gines P. Hepatorenal syndrome in cirrhosis: Pathogenesis and treatment. Gastroenterology. 2002;122:1658-1676.
-
(2002)
Gastroenterology
, vol.122
, pp. 1658-1676
-
-
Arroyo, V.1
Guevara, M.2
Gines, P.3
-
38
-
-
0036678368
-
Hepatorenal syndrome: Diagnostic accuracy clinical features, and outcome in a tertiary care centre
-
Watt K, Uhanova J, Minuk GY. Hepatorenal syndrome: diagnostic accuracy clinical features, and outcome in a tertiary care centre. Am J Gastroenterol. 2002;97:2046-2050.
-
(2002)
Am. J. Gastroenterol.
, vol.97
, pp. 2046-2050
-
-
Watt, K.1
Uhanova, J.2
Minuk, G.Y.3
-
39
-
-
0002029901
-
The hepatorenal syndrome
-
Epstein M, ed. 2nd Edition. New York: Elsevier Biomedical
-
Papper S. The hepatorenal syndrome. In: Epstein M, ed. The Kidney in Liver Disease. 2nd Edition. New York: Elsevier Biomedical; 1983:87-106.
-
(1983)
The Kidney in Liver Disease
, pp. 87-106
-
-
Papper, S.1
-
40
-
-
0027973463
-
Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis
-
Follo A, Llovet JM, Navasa M, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology. 1994;20:1495-1501.
-
(1994)
Hepatology
, vol.20
, pp. 1495-1501
-
-
Follo, A.1
Llovet, J.M.2
Navasa, M.3
-
41
-
-
0036867195
-
Liver in sepsis and systemic inflammatory response syndrome
-
Szabo G, Romics L Jr, Frendl G. Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis. 2002;6:1045-1066.
-
(2002)
Clin. Liver Dis.
, vol.6
, pp. 1045-1066
-
-
Szabo, G.1
Romics Jr., L.2
Frendl, G.3
-
42
-
-
0033527033
-
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis
-
Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403-409.
-
(1999)
N. Engl. J. Med.
, vol.341
, pp. 403-409
-
-
Sort, P.1
Navasa, M.2
Arroyo, V.3
-
43
-
-
0033970375
-
Upper gastrointestinal bleeding in patients with hepatic cirrhosis: Clinical course and mortality prediction
-
Afessa B, Kublis PS. Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction. Am J Gastroenterol. 2000;95:484-489.
-
(2000)
Am. J. Gastroenterol.
, vol.95
, pp. 484-489
-
-
Afessa, B.1
Kublis, P.S.2
-
44
-
-
0034816961
-
Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosis
-
Cardenas A, Gines P, Uriz J, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology. 2001:34:671-676.
-
(2001)
Hepatology
, vol.34
, pp. 671-676
-
-
Cardenas, A.1
Gines, P.2
Uriz, J.3
-
45
-
-
0030819439
-
Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis
-
Salo J, Gines A, Gines P, et al. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis. J Hepatol. 1997;27:645-653.
-
(1997)
J. Hepatol.
, vol.27
, pp. 645-653
-
-
Salo, J.1
Gines, A.2
Gines, P.3
-
46
-
-
0002626454
-
Effect of celecoxib on renal function in cirrhotic patients with ascites. A pilot study
-
[Abstract]
-
Guevara M, Abecasis R, Jimenez W, et al. Effect of celecoxib on renal function in cirrhotic patients with ascites. A pilot study [Abstract]; J Hepatol. 2002;36(suppl 1):203.
-
(2002)
J. Hepatol.
, vol.36
, Issue.SUPPL. 1
, pp. 203
-
-
Guevara, M.1
Abecasis, R.2
Jimenez, W.3
-
47
-
-
0027528296
-
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver
-
Gentilini P, Romanelli RG, La Villa G, et al. Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. Gastroenterology. 1993;104:588-594.
-
(1993)
Gastroenterology
, vol.104
, pp. 588-594
-
-
Gentilini, P.1
Romanelli, R.G.2
La Villa, G.3
-
48
-
-
0035433365
-
Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis
-
Gonzalez-Abraldes J, Albillos A, Banarez R, et al. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology. 2001;121:389-388.
-
(2001)
Gastroenterology
, vol.121
, pp. 388-389
-
-
Gonzalez-Abraldes, J.1
Albillos, A.2
Banarez, R.3
-
49
-
-
0034898990
-
Hemodynamic effects of the angiotensin Ii receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
-
Shepke M, Werner E, Biecker E, et al. Hemodynamic effects of the angiotensin Ii receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. Gastroenterology. 2001;121:289-395.
-
(2001)
Gastroenterology
, vol.121
, pp. 289-395
-
-
Shepke, M.1
Werner, E.2
Biecker, E.3
-
50
-
-
0033060562
-
Improvement in renal function in hepatorenal syndrome with N-acetylcysteine
-
Holt S, Goodier D, Marley R, et al. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet. 1999;353:294-295.
-
(1999)
Lancet
, vol.353
, pp. 294-295
-
-
Holt, S.1
Goodier, D.2
Marley, R.3
-
51
-
-
0032943093
-
Acute cholestasis-induced renal failure: Effects of antioxidants and ligands for the thromboxane A2 receptor
-
Holt S, Marley R, Fernando B, et al. Acute cholestasis-induced renal failure: effects of antioxidants and ligands for the thromboxane A2 receptor. Kidney Int. 1999;55:271-277.
-
(1999)
Kidney Int.
, vol.55
, pp. 271-277
-
-
Holt, S.1
Marley, R.2
Fernando, B.3
-
53
-
-
0032983535
-
Renal failure in liver disease
-
Eckardt KU. Renal failure in liver disease. Intensive Care Med. 1999;25:5-14.
-
(1999)
Intensive Care Med.
, vol.25
, pp. 5-14
-
-
Eckardt, K.U.1
-
54
-
-
0036867319
-
Liver and kidney disease
-
Wong F. Liver and kidney disease. Clin Liver Dis. 2002;6:981-1011.
-
(2002)
Clin. Liver Dis.
, vol.6
, pp. 981-1011
-
-
Wong, F.1
-
55
-
-
0036192392
-
Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation (Part I)
-
Davis CL, Gonwa TA, Wilkinson AH. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation (Part I). Liver Transpl. 2002;8:91-109.
-
(2002)
Liver Transpl.
, vol.8
, pp. 91-109
-
-
Davis, C.L.1
Gonwa, T.A.2
Wilkinson, A.H.3
-
56
-
-
0036434909
-
Significance of the fractional excretion of urea in the differential diagnosis or acute renal failure
-
Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis or acute renal failure. Kidney Int. 2002;62:2223-2229.
-
(2002)
Kidney Int.
, vol.62
, pp. 2223-2229
-
-
Carvounis, C.P.1
Nisar, S.2
Guro-Razuman, S.3
-
57
-
-
0036210275
-
Terlipressin in patients with cirrhosis and Type 1 hepatorenal syndrome: A retrospective multicenter study
-
Moreau R, Durand F, Poynrd T, et al. Terlipressin in patients with cirrhosis and Type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology. 2002;122:923-930.
-
(2002)
Gastroenterology
, vol.122
, pp. 923-930
-
-
Moreau, R.1
Durand, F.2
Poynrd, T.3
-
58
-
-
0033180281
-
Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis
-
Deschenes M, Villeneuve J. Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol. 1999;94:2193-2197.
-
(1999)
Am. J. Gastroenterol.
, vol.94
, pp. 2193-2197
-
-
Deschenes, M.1
Villeneuve, J.2
-
59
-
-
0021814770
-
Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage
-
Rimola A, Bory F, Teres J, et al. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology. 1985;5:463-467.
-
(1985)
Hepatology
, vol.5
, pp. 463-467
-
-
Rimola, A.1
Bory, F.2
Teres, J.3
-
60
-
-
0026781087
-
Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage
-
Soriano G, Guarner C, Tomas A, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology. 1992;103:1267-1272.
-
(1992)
Gastroenterology
, vol.103
, pp. 1267-1272
-
-
Soriano, G.1
Guarner, C.2
Tomas, A.3
-
61
-
-
0028341096
-
Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage
-
Blaise M, Pateron D, Trinchet J, et al. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1994;20:34-38.
-
(1994)
Hepatology
, vol.20
, pp. 34-38
-
-
Blaise, M.1
Pateron, D.2
Trinchet, J.3
-
62
-
-
0029829650
-
Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection
-
Pauwels A, Mostefa-Kara N, Debenes B, et al. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection. Hepatology. 1996;24:802-806.
-
(1996)
Hepatology
, vol.24
, pp. 802-806
-
-
Pauwels, A.1
Mostefa-Kara, N.2
Debenes, B.3
-
63
-
-
0032105450
-
The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding
-
Hsieh W, Lin H, Hwang S, et al. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol. 1998;93:962-966.
-
(1998)
Am. J. Gastroenterol.
, vol.93
, pp. 962-966
-
-
Hsieh, W.1
Lin, H.2
Hwang, S.3
-
64
-
-
0032993780
-
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis
-
Bernard B, Grange J, Khac EN, et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology. 1999;29:1655-1661.
-
(1999)
Hepatology
, vol.29
, pp. 1655-1661
-
-
Bernard, B.1
Grange, J.2
Khac, E.N.3
-
66
-
-
0031979978
-
Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage
-
Goulis J, Armonis A, Patch D, et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1998;27:1207-1212.
-
(1998)
Hepatology
, vol.27
, pp. 1207-1212
-
-
Goulis, J.1
Armonis, A.2
Patch, D.3
-
67
-
-
0025151559
-
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial
-
Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology. 1990;12:716-724.
-
(1990)
Hepatology
, vol.12
, pp. 716-724
-
-
Gines, P.1
Rimola, A.2
Planas, R.3
-
68
-
-
0023907437
-
Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis
-
Gines P, Tito L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology. 1988;84:1493-1502.
-
(1988)
Gastroenterology
, vol.84
, pp. 1493-1502
-
-
Gines, P.1
Tito, L.2
Arroyo, V.3
-
69
-
-
10144248967
-
Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis
-
Gines P, Fernandez-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology. 1996;111:1002-1010.
-
(1996)
Gastroenterology
, vol.111
, pp. 1002-1010
-
-
Gines, P.1
Fernandez-Esparrach, G.2
Monescillo, A.3
-
70
-
-
0022486868
-
Rapid diuresis in patients with ascites from chronic liver disease: The importance of peripheral edema
-
Pockros PJ, Reynolds TB. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. Gastroenterology. 1986;90:1827-1833.
-
(1986)
Gastroenterology
, vol.90
, pp. 1827-1833
-
-
Pockros, P.J.1
Reynolds, T.B.2
-
71
-
-
25144446617
-
Aminoglycoside toxicity in cirrhosis. Value of urinary beta-2 microglobulin to discriminate functional renal failure from acute tubular damage
-
Cabrera J, Arroyo V, Ballesta AM, et al. Aminoglycoside toxicity in cirrhosis. Value of urinary beta-2 microglobulin to discriminate functional renal failure from acute tubular damage. Gastroenterology. 1996;111:1002-1010.
-
(1996)
Gastroenterology
, vol.111
, pp. 1002-1010
-
-
Cabrera, J.1
Arroyo, V.2
Ballesta, A.M.3
-
72
-
-
0035184982
-
New challenge of hepatorenal syndrome: Prevention and treatment
-
Wong F, Blendis L. New challenge of hepatorenal syndrome: prevention and treatment. Hepatology. 2001;34:1242-1251.
-
(2001)
Hepatology
, vol.34
, pp. 1242-1251
-
-
Wong, F.1
Blendis, L.2
-
73
-
-
84942475979
-
Response to dopamine hydrochloride in the hepatorenal syndrome
-
Bennett WM, Keeffe E, Melnyk C, et al. Response to dopamine hydrochloride in the hepatorenal syndrome. Arch Intern Med. 1975;135:964-971.
-
(1975)
Arch. Intern. Med.
, vol.135
, pp. 964-971
-
-
Bennett, W.M.1
Keeffe, E.2
Melnyk, C.3
-
74
-
-
0025945029
-
Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis
-
Bacq Y, Gaudin C, Hadengue A, et al. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. Hepatology. 1991;14:483-487.
-
(1991)
Hepatology
, vol.14
, pp. 483-487
-
-
Bacq, Y.1
Gaudin, C.2
Hadengue, A.3
-
75
-
-
0036326383
-
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study
-
Duvoux C, Zanditenas D, Hezode C, et al. Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology. 2002;36:374-380.
-
(2002)
Hepatology
, vol.36
, pp. 374-380
-
-
Duvoux, C.1
Zanditenas, D.2
Hezode, C.3
-
76
-
-
0026576720
-
Renal effects in cirrhotic patients with avid sodium retention of atrial natriuretic factor injection during norepinephrine infusion
-
Badalamenti S, Borroni G, Lorenzano E, Incerti P, Salerno F. Renal effects in cirrhotic patients with avid sodium retention of atrial natriuretic factor injection during norepinephrine infusion. Hepatology. 1992;15:824-829.
-
(1992)
Hepatology
, vol.15
, pp. 824-829
-
-
Badalamenti, S.1
Borroni, G.2
Lorenzano, E.3
Incerti, P.4
Salerno, F.5
-
77
-
-
0033065188
-
Reversal of type I hepatorenal syndrome with the administration of midodrine and octreotide
-
Angeli P, Volpin R, Gerunda G, et al. Reversal of type I hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology. 1999;29:1690-1697.
-
(1999)
Hepatology
, vol.29
, pp. 1690-1697
-
-
Angeli, P.1
Volpin, R.2
Gerunda, G.3
-
78
-
-
3042696433
-
The use of midodrine, octreotide and transjugular intrahepatic portosystemic stent shunt in the treatment of cirrhotic patients with ascites and renal dysfunction including hepatorenal syndrome
-
Wong F, Pantea L, Sniderman K. The use of midodrine, octreotide and transjugular intrahepatic portosystemic stent shunt in the treatment of cirrhotic patients with ascites and renal dysfunction including hepatorenal syndrome. Hepatology. 2004;40:55-64.
-
(2004)
Hepatology
, vol.40
, pp. 55-64
-
-
Wong, F.1
Pantea, L.2
Sniderman, K.3
-
79
-
-
0037784209
-
Octreotide in hepatorenal syndrome: A randomized, double-blind, placebo-controlled, crossover study
-
Pomier-Layrargues G, Paquin SC, Hassoun Z, et al. Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study. Hepatology. 2003;38:238-243.
-
(2003)
Hepatology
, vol.38
, pp. 238-243
-
-
Pomier-Layrargues, G.1
Paquin, S.C.2
Hassoun, Z.3
-
80
-
-
0025203997
-
Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration
-
Fevery J, Van Cutsem E, Nevens F, et al. Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration. J Hepatol. 1990;11:153-158.
-
(1990)
J. Hepatol.
, vol.11
, pp. 153-158
-
-
Fevery, J.1
Van Cutsem, E.2
Nevens, F.3
-
81
-
-
0027397891
-
Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure
-
Gines A, Salmeron JM, Gines P, et al. Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure. J Hepatol. 1993;17:220-226.
-
(1993)
J. Hepatol.
, vol.17
, pp. 220-226
-
-
Gines, A.1
Salmeron, J.M.2
Gines, P.3
-
82
-
-
0024501094
-
Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis
-
Lenz K, Hortnagl H, Druml W, et al. Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis. Gut. 1989;30:90-96.
-
(1989)
Gut
, vol.30
, pp. 90-96
-
-
Lenz, K.1
Hortnagl, H.2
Druml, W.3
-
83
-
-
0025945527
-
Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor
-
Lenz K, Hortnagl H, Druml W, et al. Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology. 1991;101:1060-1067.
-
(1991)
Gastroenterology
, vol.101
, pp. 1060-1067
-
-
Lenz, K.1
Hortnagl, H.2
Druml, W.3
-
84
-
-
0030444514
-
Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome
-
Salo J, Gines A, Quer JC, et al. Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome. J Hepatol. 1996;25:916-923.
-
(1996)
J. Hepatol.
, vol.25
, pp. 916-923
-
-
Salo, J.1
Gines, A.2
Quer, J.C.3
-
85
-
-
0032885451
-
Gerbes Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine
-
Gulberg V, Bilzer M, Gerbes. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine. Hepatology. 1999;30:870-875.
-
(1999)
Hepatology
, vol.30
, pp. 870-875
-
-
Gulberg, V.1
Bilzer, M.2
-
86
-
-
0031962226
-
Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion
-
Guevara M, Gines P, Fernandez-Esparrach G, et al. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology. 1998;27:35-41.
-
(1998)
Hepatology
, vol.27
, pp. 35-41
-
-
Guevara, M.1
Gines, P.2
Fernandez-Esparrach, G.3
-
87
-
-
0033982045
-
Central and systemic hemodynamic effects of terlipressin in portal hypertensive patients
-
Moller S, Hansen EF, Becker U, et al. Central and systemic hemodynamic effects of terlipressin in portal hypertensive patients. Liver. 2000;20:51-59.
-
(2000)
Liver
, vol.20
, pp. 51-59
-
-
Moller, S.1
Hansen, E.F.2
Becker, U.3
-
88
-
-
0032191718
-
Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome
-
Hadengue A, Gadano A, Moreau R, et al. Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol. 1998;29:565-570.
-
(1998)
J. Hepatol.
, vol.29
, pp. 565-570
-
-
Hadengue, A.1
Gadano, A.2
Moreau, R.3
-
89
-
-
0033916288
-
Terlipressin plus albumin infusion: An effective and safe therapy of hepatorenal syndrome
-
Uriz J, Gines P, Cardenas A, et al. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. J Hepatol. 2000;33:43-48.
-
(2000)
J. Hepatol.
, vol.33
, pp. 43-48
-
-
Uriz, J.1
Gines, P.2
Cardenas, A.3
-
90
-
-
0037300902
-
Beneficial effects of terlipressin in hepatorenal syndrome: A prospective, randomized placebo-controlled clinical trial
-
Solanki P, Chawla A, Garg R, et al. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol. 2003;18:152-156.
-
(2003)
J. Gastroenterol. Hepatol.
, vol.18
, pp. 152-156
-
-
Solanki, P.1
Chawla, A.2
Garg, R.3
-
91
-
-
0036174425
-
Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: Results of a multicentre pilot study
-
Halimi C, Bonnard P, Bernard B, et al. Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study. Eur J Gastroenterol Hepatol. 2002;14:153-158.
-
(2002)
Eur. J. Gastroenterol. Hepatol.
, vol.14
, pp. 153-158
-
-
Halimi, C.1
Bonnard, P.2
Bernard, B.3
-
92
-
-
0036787604
-
Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study
-
Ortega R, Gines P, Uriz J, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology. 2002;36:941-948.
-
(2002)
Hepatology
, vol.36
, pp. 941-948
-
-
Ortega, R.1
Gines, P.2
Uriz, J.3
-
93
-
-
0041314005
-
Terlipressin plus hydroxy-ethyl starch infusion: An effective treatment for hepatorenal syndrome
-
Saner FH, Fruhauf NR, Schafers RF, et al. Terlipressin plus hydroxy-ethyl starch infusion: an effective treatment for hepatorenal syndrome. Eur J Gastroenterol Hepatol. 2003;15:925-927.
-
(2003)
Eur. J. Gastroenterol. Hepatol.
, vol.15
, pp. 925-927
-
-
Saner, F.H.1
Fruhauf, N.R.2
Schafers, R.F.3
-
94
-
-
0026490970
-
Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome
-
Moore K, Wendon J, Frazer M, et al. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med. 1992;327:1774-1778.
-
(1992)
N. Engl. J. Med.
, vol.327
, pp. 1774-1778
-
-
Moore, K.1
Wendon, J.2
Frazer, M.3
-
95
-
-
0036137009
-
Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure
-
Anand R, Harry D, Holt S, et al. Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure. Gut. 2002;50:111-117.
-
(2002)
Gut
, vol.50
, pp. 111-117
-
-
Anand, R.1
Harry, D.2
Holt, S.3
-
96
-
-
0033804058
-
Plasma levels of endothelin-1 in patients with the hepatorenal syndrome after successful liver transplantation
-
Bachmann-Brandt S, Bittner I, Neuhaus P, et al. Plasma levels of endothelin-1 in patients with the hepatorenal syndrome after successful liver transplantation. Transpl Int. 2000;13:357-362.
-
(2000)
Transpl. Int.
, vol.13
, pp. 357-362
-
-
Bachmann-Brandt, S.1
Bittner, I.2
Neuhaus, P.3
-
97
-
-
0029786171
-
Amelioration of hepatorenal syndrome with selective endothelin-A antagonist
-
Soper CP, Latif AB, Bending MR. Amelioration of hepatorenal syndrome with selective endothelin-A antagonist. Lancet. 1996;347:1842-1843.
-
(1996)
Lancet
, vol.347
, pp. 1842-1843
-
-
Soper, C.P.1
Latif, A.B.2
Bending, M.R.3
-
98
-
-
0034465251
-
Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial
-
Akriviadis E, Botla R, Briggs W, et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:1637-1648.
-
(2000)
Gastroenterology
, vol.119
, pp. 1637-1648
-
-
Akriviadis, E.1
Botla, R.2
Briggs, W.3
-
99
-
-
0035671695
-
Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system
-
Mitzner SR, Klammt S, Peszynski P, et al. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system. Ther Apher. 2001;5:417-422.
-
(2001)
Ther. Apher.
, vol.5
, pp. 417-422
-
-
Mitzner, S.R.1
Klammt, S.2
Peszynski, P.3
-
100
-
-
0034109694
-
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial
-
Mitzner SR, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl. 2000;6:277-286.
-
(2000)
Liver Transpl.
, vol.6
, pp. 277-286
-
-
Mitzner, S.R.1
Stange, J.2
Klammt, S.3
-
101
-
-
0027957930
-
The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding
-
Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994;330:165-171.
-
(1994)
N. Engl. J. Med.
, vol.330
, pp. 165-171
-
-
Rossle, M.1
Haag, K.2
Ochs, A.3
-
102
-
-
0028913420
-
Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters
-
Quiroga J, Sangro B, N ez M. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology. 1995:21;986-994.
-
(1995)
Hepatology
, vol.21
, pp. 986-994
-
-
Quiroga, J.1
Sangro, B.2
Sangro, N.3
Sangro, M.4
-
103
-
-
0031042630
-
The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt
-
Wong F, Sniderman K, Liu P, et al. The mechanism of the initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology. 1997;112:899-907.
-
(1997)
Gastroenterology
, vol.112
, pp. 899-907
-
-
Wong, F.1
Sniderman, K.2
Liu, P.3
-
104
-
-
0031721408
-
Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: Comparison of patients with ascites, with refractory ascites, or without Ascites
-
Gerbes AL, Gulberg V, Waggershauser T. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: Comparison of patients with ascites, with refractory ascites, or without Ascites. Hepatology. 1998;28:683-688.
-
(1998)
Hepatology
, vol.28
, pp. 683-688
-
-
Gerbes, A.L.1
Gulberg, V.2
Waggershauser, T.3
-
105
-
-
0033104831
-
Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunt for refractory ascites
-
Wong W, Liu P, Blendis L, et al. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunt for refractory ascites. Am J Med. 1999;106:315-322.
-
(1999)
Am. J. Med.
, vol.106
, pp. 315-322
-
-
Wong, W.1
Liu, P.2
Blendis, L.3
-
106
-
-
0042429572
-
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems
-
Guevara M, Gines P, Bandi JC, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology. 1998;28:416-422.
-
(1998)
Hepatology
, vol.28
, pp. 416-422
-
-
Guevara, M.1
Gines, P.2
Bandi, J.C.3
-
107
-
-
0031034917
-
Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS)
-
Martinet JP, Fenyves D, Legault L, et al. Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS). Dig Dis Sci. 1997;42:161-166.
-
(1997)
Dig. Dis. Sci.
, vol.42
, pp. 161-166
-
-
Martinet, J.P.1
Fenyves, D.2
Legault, L.3
-
108
-
-
0027252834
-
Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency
-
Lake JR, Ring E, LaBerge J, et al. Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency. Transplant Proc. 1993;25:1766-1767.
-
(1993)
Transplant Proc.
, vol.25
, pp. 1766-1767
-
-
Lake, J.R.1
Ring, E.2
LaBerge, J.3
-
109
-
-
0029010937
-
Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt
-
Spahr L, Fenyves D, Nguyen VV, et al. Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt. Am J Gastroenterol. 1995;90:1169-1171.
-
(1995)
Am. J. Gastroenterol.
, vol.90
, pp. 1169-1171
-
-
Spahr, L.1
Fenyves, D.2
Nguyen, V.V.3
-
110
-
-
0036892328
-
Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis
-
Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002;123:1839-1847.
-
(2002)
Gastroenterology
, vol.123
, pp. 1839-1847
-
-
Gines, P.1
Uriz, J.2
Calahorra, B.3
-
111
-
-
0029001750
-
The transjugular intrahepatic portosystemic stent shunt procedure for refractory ascites
-
Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent shunt procedure for refractory ascites. N Engl J Med. 1995;332:1192-1197.
-
(1995)
N. Engl. J. Med.
, vol.332
, pp. 1192-1197
-
-
Ochs, A.1
Rossle, M.2
Haag, K.3
-
112
-
-
0033923689
-
Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: Effects in patients with organic or functional renal failure
-
Michl P, Gulberg V, Blitzer M, et al. Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: effects in patients with organic or functional renal failure. Scan J Gastroenterol. 2000;35:654-658.
-
(2000)
Scan. J. Gastroenterol.
, vol.35
, pp. 654-658
-
-
Michl, P.1
Gulberg, V.2
Blitzer, M.3
-
113
-
-
0342803192
-
A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites
-
Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000;342:1701-1707.
-
(2000)
N. Engl. J. Med.
, vol.342
, pp. 1701-1707
-
-
Rossle, M.1
Ochs, A.2
Gulberg, V.3
-
114
-
-
0037370136
-
The North American Study of Treatment for Refractory Ascites (NASTRA)
-
Sanyal AJ, Genning C, Reddy RK, et al. The North American Study of Treatment for Refractory Ascites (NASTRA). Gastroenterology. 2003;124:634-641.
-
(2003)
Gastroenterology
, vol.124
, pp. 634-641
-
-
Sanyal, A.J.1
Genning, C.2
Reddy, R.K.3
-
115
-
-
9444257018
-
Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial
-
Lebrec D, Giuily N, Hadengue A, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol. 1996;25:135-144.
-
(1996)
J. Hepatol.
, vol.25
, pp. 135-144
-
-
Lebrec, D.1
Giuily, N.2
Hadengue, A.3
-
116
-
-
4544387932
-
A randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites
-
in press
-
Salerno F, Merli M, Riggio O. et al. A randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology. 2004; in press.
-
(2004)
Hepatology
-
-
Salerno, F.1
Merli, M.2
Riggio, O.3
-
117
-
-
0034106289
-
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
-
Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31;864-871.
-
(2000)
Hepatology
, vol.31
, pp. 864-871
-
-
Malinchoc, M.1
Kamath, P.S.2
Gordon, F.D.3
-
118
-
-
0033915685
-
Improving prognosis in hepatorenal syndrome
-
McCormick PA. Improving prognosis in hepatorenal syndrome. Gut. 2000;47:166-167.
-
(2000)
Gut
, vol.47
, pp. 166-167
-
-
McCormick, P.A.1
-
119
-
-
0028363114
-
Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study
-
Sanyal AJ, Freedman AM, Shiffman ML, et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study. Hepatology. 1994;20:46-55.
-
(1994)
Hepatology
, vol.20
, pp. 46-55
-
-
Sanyal, A.J.1
Freedman, A.M.2
Shiffman, M.L.3
-
120
-
-
0026096518
-
Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients
-
Gonwa TA, Morris CA, Goldstein RM, et al. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome-experience in 300 patients. Transplantation. 1991;51:428-430.
-
(1991)
Transplantation
, vol.51
, pp. 428-430
-
-
Gonwa, T.A.1
Morris, C.A.2
Goldstein, R.M.3
-
121
-
-
0028912110
-
Impact of pretransplant renal function on survival after liver transplantation
-
Gonwa TA, Klintmalm GB, Levy M, et al. Impact of pretransplant renal function on survival after liver transplantation. Transplantation. 1995;59:361-365.
-
(1995)
Transplantation
, vol.59
, pp. 361-365
-
-
Gonwa, T.A.1
Klintmalm, G.B.2
Levy, M.3
|